“On conducting an internal analysis of corruption risks in the “West Kazakhstan Medical University M.Ospanov” – Марат Оспанов атындағы Батыс Қазақстан медицина университеті


“On conducting an internal analysis of corruption risks in the “West Kazakhstan Medical University M.Ospanov”

On March 16, 2023, the Head of the Staff of the Ministry of Health of the Republic of Kazakhstan approved the roadmap for the implementation of the standard basic route No. 4 “prevention and combating corruption” for 2023. In particular, the schedule for conducting an internal analysis of corruption risks (hereinafter referred to as the WACR) in subordinate organizations of the Ministry of Health of the Republic of Kazakhstan has been approved, where the WACR is scheduled for June-July 2023.

In pursuance of the roadmap, the “M.Ospanov West Kazakhstan Medical University” (hereinafter referred to as the University) is scheduled to begin conducting an internal analysis of corruption risks from November 15, 2023. Internal analysis of corruption risks is recommended to be carried out within a period not exceeding 30 working days.

The main purpose of the WACR is to identify and study the causes and conditions that contribute to the commission of corruption offenses at the University.

Internal analysis of corruption risks at the University is carried out by a working group created by the decision (Order) of the Chairman of the Board-Rector.

The main direction of the analysis of corruption risks are: Analysis of legal acts and internal documents regulating the activities of the University and its organizational and managerial activities for the presence of corruption risks. The main direction of the analysis of corruption risks are: Analysis of legal acts and internal documents regulating the activities of the University and its organizational and managerial activities for the presence of corruption risks.

Heads of structural divisions and University staff should assist the working group on the identification and elimination of corruption risks.

Compliance Officer                                R. Sugralin